When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia

Author： Lamble Adam   Phelan Rachel   Burke Michael  

Publisher： MDPI

E-ISSN： 2077-0383|6|7|66-66

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.6, Iss.7, 2017-07, pp. : 66-66

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

By Mosna Federico   Capelli Debora   Gottardi Michele  

Journal of Clinical Medicine, Vol. 6, Iss. 6, 2017-06 ,pp. : 57-57

MDPI

Access to resources Recommend Favorite

Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia

By  

Clinical Case Reports, Vol. 3, Iss. 10, 2015-10 ,pp. : 814-816

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic Bullous Disease of Childhood in a Patient with Acute Lymphoblastic Leukemia: Possible Induction by a Drug

By Polat Muhterem  

American Journal of Clinical Dermatology, Vol. 8, Iss. 6, 2007-01 ,pp. : 389-391

Adis International

Access to resources Recommend Favorite

Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

By Keam Susan J.  

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite

Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure

By  

Clinical Case Reports, Vol. 6, Iss. 1, 2018-01 ,pp. : 155-161

John Wiley & Sons Inc

Access to resources Recommend Favorite